For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.91 in the prior trading day, Verrica Pharmaceuticals Inc (NASDAQ: VRCA) closed at $2.80, down -3.78%. In other words, the price has decreased by -$3.78 from its previous closing price. On the day, 1.35 million shares were traded. VRCA stock price reached its highest trading level at $2.89 during the session, while it also had its lowest trading level at $2.7.
Ratios:
Our goal is to gain a better understanding of VRCA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.23 and its Current Ratio is at 2.36.
On March 22, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $10.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on February 13, 2023, whereas the target price for the stock was revised from $4 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 22 ’24 when White Ted sold 32,469 shares for $7.06 per share. The transaction valued at 229,231 led to the insider holds 250,121 shares of the business.
White Ted sold 154 shares of VRCA for $1,075 on Jul 23 ’24. The PRESIDENT AND CEO now owns 249,967 shares after completing the transaction at $6.98 per share. On Jul 22 ’24, another insider, Bonaccorso Joe, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 25,461 shares for $7.06 each. As a result, the insider received 179,755 and left with 106,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRCA now has a Market Capitalization of 119472080 and an Enterprise Value of 133851952. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.59. Its current Enterprise Value per Revenue stands at 9.624 whereas that against EBITDA is -1.727.
Stock Price History:
Over the past 52 weeks, VRCA has reached a high of $11.41, while it has fallen to a 52-week low of $2.72. The 50-Day Moving Average of the stock is -60.78%, while the 200-Day Moving Average is calculated to be -54.35%.
Shares Statistics:
The stock has traded on average 369.12K shares per day over the past 3-months and 1329410 shares per day over the last 10 days, according to various share statistics. A total of 42.41M shares are outstanding, with a floating share count of 25.91M. Insiders hold about 39.28% of the company’s shares, while institutions hold 43.77% stake in the company. Shares short for VRCA as of 1722384000 were 3686949 with a Short Ratio of 9.99, compared to 1719532800 on 3914403. Therefore, it implies a Short% of Shares Outstanding of 3686949 and a Short% of Float of 19.66.
